Crystal structure of trans-di­chlorido­(1,4,8,11-tetra­aza­cyclo­tetra­decane-κ(4) N)chromium(III) bis­(form­amide-κO)(1,4,8,11-tetra­aza­cyclo­tetra­decane-κ(4) N)chromium(III) bis­[tetra­chlorido­zincate(II)]

The structure of the title compound, [CrCl(2)(C(10)H(24)N(4))][Cr(HCONH(2))(2)(C(10)H(24)N(4))][ZnCl(4)](2) (C(10)H(24)N(4) = 1,4,8,11-tetra­aza­cyclo­tetra­decane, cyclam; HCONH(2) = formamide, fa), has been determined from synchrotron X-ray data. The asymmetric unit contains two independent halves of the [CrCl(2)(cyclam)](+) and [Cr(fa)(cyclam)](3+) cations, and one tetra­chlorido­zincate anion. In each complex cation, the Cr(III) ion is coordinated by the four N atoms of the cyclam ligand in the equatorial plane and two Cl ligands or two O-bonded formamide mol­ecules in a trans axial arrangement, displaying a distorted octa­hedral geometry with crystallographic inversion symmetry. The Cr—N(cyclam) bond lengths are in the range 2.061 (2) to 2.074 (2) Å, while the Cr—Cl and Cr—O(fa) bond distances are 2.3194 (7) and 1.9953 (19) Å, respectively. The macrocyclic cyclam moieties adopt the centrosymmetric trans-III conformation with six- and five-membered chelate rings in chair and gauche conformations. The crystal structure is stabilized by inter­molecular hydrogen bonds involving the NH or CH groups of cyclam and the NH(2) group of coordinated formamide as donors, and Cl atoms of the ZnCl(4) (2−) anion as acceptors.